1.Neuropsychological Profile and Problems in Vascular Cognitive Impairment(review)
Aihong ZHOU ; Jianping JIA ; Baoquan MIN
Chinese Journal of Rehabilitation Theory and Practice 2008;14(3):214-216
Vascular cognitive impairment(VCI)is a continuum including early cognitive impairment to dementia caused by cerebral vascular disease.VCI was introduced to identify cognitive decline in early stage for valid treatment.There is inconsistence about the cognitive impairment profile in VCI.This paper reviewed the neuropsychological features of VCI.The problems existed in researches were also discussed.
2.Effect of Qingluo Tongbi Granule-containing serum on osteoblasts and osteoclasts
Changhua CHEN ; Taihui FANG ; Lingling ZHOU ; Xueping ZHOU ; Min JIA
Chinese Traditional Patent Medicine 1992;0(01):-
AIM: To observe the effect of Qingluo Tongbi Granule(QLTBG)——containing serum on the proliferation of osteoblasts(OB) and osteoclasts(OC),the activity of AKP of OB. METHODS: (1) OB were separated from the skull of SD rats aged 1 d and OC from the thighbone and shinbone of SD rats aged 5 d.(2) The proliferation of OB and OC was detected by MTT method,and the activity of AKP of OB was examined by diazol method. RESULTS: The proliferation capability of OB was strengthened markedly by the rat sera containing 7.2,14.4 g/kg QLTBG,which could reinforce the activity of AKP obviously as well,while the proliferation of OB was inhibited remarkably by the rat sera containing 3.6,7.2,14.4 g/kg QLT. CONCLUSION: The sera containing QLTBG could enhance the proliferation of OB and the activity of AKP,restrain the proliferation of OC simultaneously.
3.Effects of Qingluotongbi granule on RANKLE expression in T lymphocytes from RA patients
Xueping ZHOU ; Lingling ZHOU ; Min JIA ; Mingyan WANG ; Yan LU
Chinese Journal of Immunology 1999;0(12):-
Objective:To investigate the effects of Qingluotongbi granule(QLT) on RANKL(receptor activator of nuclear factor-?B ligand) expression in peripheral blood T lymphocytes of RA patients.Methods:RANKL expression of peripheral blood T lymphocyts was examined using flow cytometry.Six cases of RA patients were enrolled with six healthy volunteers as the control.Meanwhile examination for the level of RANKL expression in T cells after incubation in presense of QLT-contained serum was observed.Results:RANKL expression of peripheral blood T lymphocytes was much higher in active state RA patients than in healthy people(P
5.Neuropsychological profile of mild cognitive impairment of different etiology
Aihong ZHOU ; Jianping JIA ; Baoquan MIN ; Peijie YANG
Chinese Journal of Neurology 2008;41(4):242-246
Objective To determine the cognitive profile of mild cognitive impairment due to subcortieal small vessel disease(MCI-SSVD)and mild cognitive impairment caused by Alzheimer's disease(MCI-AD)and to establish the best way of differentiating.Methods Extensive neuropsychological tests covenng 5 cognitive domains were performed on 45 MCI-SSVD patients,30 MCI-AD patients,and 61healthy controls.The impaired domains in patient groups were determined.Tests valuable in discriminating MCI-SSVD and MCI-AD were established using logistie regression analysis.Results Both patient groups showed impairments in multiple cognitive domains.The auditory verbal learning test immediate recall(control group 55.48±5.33;MCI-SSVD group 38.55±8.04;MCI-AD group 34.93±8.79;F=113.407,P=0.000),short time delayed recall(control group 13.34±1.38;MCI-SSVD group 8.47±2.18;MCI-AD group 4.06±2.87;F=216.284,P=0.000),and long time delayed recall(control group13.18±1.19;MCI-SSVD group 8.58±2.02;MCI-AD group 3.93±2.84;F=239.394,P=0.000)impaired most.Compared with MCI-SSVD,MCI-AD patients did worse in memory assessments(P=0.000),but better in mental processing and visuoconstruction(P=0.000-0.023).Two tests tapping memory and processing speed in combination could identify 93.3%MCI-SSVD patients and 93.3% MCI-AD patients correctly.Conclusions Current study indicates that both MCI-SSVD and MCI-AD,varying significantly in memory and mental processing speed,have a multiple-domain cognitive deficit,with memory impaired most seriously.Tests involving these 2 domains might be useful in differentiating MCI-SSVD from MCI-AD.
6.Antimotion sickness effects of ginsenosides combined with dexamethasone in rats.
Lin JIA ; Wanyin WANG ; Limei ZHOU ; Fengfeng MO ; Min LI
Journal of Integrative Medicine 2010;8(4):358-62
Objective: To investigate the antimotion sickness effects of ginsenosides combined with dexamethasone in rats. Methods: Fifty SD rats were randomly divided into 5 groups: normal saline, scopolamine-treated, ginsenosides-treated, dexamethasone-treated and ginsenosides plus dexamethasone-treated groups. There were 10 rats in each group. The rats in each group were fed with corresponding ingredients respectively, and then the rats were exposed to abnormal acceleration for one hour. The motion sickness index, the level of kaolin consumption and the course and time of spontaneous activity were observed. Results: The motion sickness index and the level of kaolin consumption of acceleration-exposed rats in ginsenosides plus dexamethasone-treated group were significantly lower than those in normal saline group. And the course and time of spontaneous activity of acceleration-exposed rats in ginsenosides plus dexamethasone-treated group were significantly higher than those in normal saline group. The level of body weight increment of acceleration-exposed rats in ginsenosides plus dexamethasone-treated group was significantly higher than that in dexamethasone-treated group. Conclusion: Ginsenosides combined with dexamethasone can significantly increase tolerance to acceleration of rats, and the drug combination can decrease side effects of methylprednisolone, such as body weight loss.
7.Association between the apolipoprotein E gene polymorphism and the genetic sensitivity of sporadic Alzheimer's diseases.
Jianping JIA ; Jin ZHANG ; Min XU ; Weidong ZHOU
Chinese Journal of Geriatrics 2000;0(04):-
Objective To study the relationship between apoE alleles and the occurrence of sporadic Alzheimer's disease (SAD) and to compare the alleles relating to the SAD and the vascular dementia (VD). Methods The polymorphism of apoE gene was detected using polymerase chain reaction restriction fragment length polymorphism(PCR RFLP) technique for 58 patients with SAD, 59 patients with VD and 60 normal controls. Results The frequencies of the ?4 and 3/4 genotype in SAD group(19 82% and 25 86%)were significantly higher than those in the controls(5 00% and 6 67%, ? 2=13 87, P 0 05). Conclusions The apoE ?4 allele is a genetic risk factor for the occurrence of SAD.
8.Clinical value of human papillomavirus genotype distribution in HPV infection
Ying JIA ; Min ZHOU ; Jin WU ; Liangdan TANG
Journal of Third Military Medical University 2003;0(23):-
Objective To analyze the distribution of human papillomavirus (HPV) genotype in the diseases associated with HPV infection and explore the role of HPV genotype in these diseases. Methods Retrospective analysis was carried out to compare HPV genotypes of 353 outpatients suffering the diseases associated with HPV infection including cervical caner,cervical intraepithelial neoplasia (CIN),genital duc condyloma,and subclinical cervical human papillomavirus infection (SPI) in our department from January to October 2008. HybriMax were used to detect HPV genotype. The distribution data of HPV genotype were statistically analyzed. Results Totally 176 HPV positive females were found with a positive rate of 49.86%. HPV positive rate in cervical cancer was 100%,and all of them were high risk HPV. The positive rate was increased with the severity of CIN,and the higher histological-grade was,the higher HPV positive rate was (P
10.Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients.
Zhuo-Jia CHEN ; Xue-Ding WANG ; Lie-Min ZHOU ; Zi-Yan FANG ; Hong-Sheng WANG ; Jia-Li LI ; Jue-Qian ZHOU ; Hong-Bing HUANG ; Min HUANG
Acta Pharmaceutica Sinica 2014;49(4):530-534
To investigate the effects of carbamazepine (CBZ) on the plasma concentrations of valproic acid (VPA) and its toxic metabolite 2-propyl-4-pentenoic acid (4-ene VPA) in epileptic patients, the plasma concentrations of VPA and 4-ene VPA were determined, and the effect of CBZ on pharmacokinetics of VPA was evaluated. All patients had been divided into two groups (VPA group, n = 87; and VPA+CBZ group, n = 19). As compared to VPA group, the combination of CBZ significantly (P < 0.01) decreased the trough concentration of VPA [VPA group, (69.5 +/- 28.8) microg x mL(-1); VPA+CBZ group, (46.3 +/- 25.6) microg x mL(-1)] and does-adjusted VPA trough concentration [VPA group, (4.89 +/- 2.21) microg x mL(-1) x mg(-1) x kg(-1); VPA+CBZ group, (3.14 +/- 1.74) microg x mL(-1) x mg(-1) x kg(-1)]. However, the addition of CBZ did not influence the concentration of 4-ene VPA. The present study revealed that coadministration of CBZ can reduce VPA plasma concentration and may impact VPA clinical effect, therefore therapeutic drug mornitoring of VPA should be used when combined use of CBZ and VPA.
Adolescent
;
Adult
;
Anticonvulsants
;
blood
;
pharmacokinetics
;
therapeutic use
;
Carbamazepine
;
blood
;
pharmacokinetics
;
therapeutic use
;
Drug Interactions
;
Drug Therapy, Combination
;
Epilepsy
;
blood
;
drug therapy
;
Fatty Acids, Monounsaturated
;
blood
;
Female
;
Humans
;
Male
;
Valproic Acid
;
blood
;
pharmacokinetics
;
therapeutic use
;
Young Adult